テネシーにおける直腸がんの臨床試験
テネシー内の拠点で、直腸がんに関する11件の研究が参加者を募集しています。
テネシー内の都市
公式研究テキスト（英語）
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07283939Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Sarah Cannon Research Institue, Nashville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- Tennessee Oncology, PLLC, Nashville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/21更新 · NCT07629960A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
- GSK Investigational Site, Nashville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07213609Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
被験者募集中
45歳〜70歳 · 全性別 · 2026/09/02更新 · NCT05080673ColoSeal™ ICD System Anastomotic Protection Pivotal Study
- Vanderbilt University Medical Center, Nashville
被験者募集中
22歳〜75歳 · 全性別 · 2026/08/21更新 · NCT07429110Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
- The West Clinic - Wolf River, Germantown
- Vanderbilt University/Ingram Cancer Center, Nashville
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/14更新 · NCT06205485A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Vanderbilt University Medical Center, Nashville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/12更新 · NCT06051695A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
- SCRI Oncology Partners, Nashville
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/12更新 · NCT07011576Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Sarah Cannon Research Institute, Nashville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/06更新 · NCT06239194SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Memphis
- Massive Bio SYNERGY-AI site, Nashville
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。